Beam Therapeutics(BEAM) - 2022 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Beam Therapeutics Inc. (Exact name of Registrant as specified in its Charter) Delaware 81-5238376 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 238 Main Street Cambridge, MA 02142 (Address of principal executive of ices) (Zip Code) Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share BEAM Nasdaq Global Select Market S ...